Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Pharmacokinetic Models: Overview01:20

Pharmacokinetic Models: Overview

505
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
505
Model Approaches for Pharmacokinetic Data: Compartment Models01:14

Model Approaches for Pharmacokinetic Data: Compartment Models

59
Compartmental analysis is a widely adopted approach to characterizing drug pharmacokinetics. It uses compartment models that conceptualize the body as a collection of reversibly communicating compartments, each representing a group of tissues exhibiting similar drug distribution characteristics. The movement rate of the drug between these compartments is typically described by first-order kinetics.
Two primary types of compartment models are recognized: mammillary and catenary. The more...
59
Multicompartment Models: Overview01:14

Multicompartment Models: Overview

65
Multicompartment models are mathematical constructs that depict how drugs are distributed and eliminated within the body. They segment the body into several compartments, symbolizing various physiological or anatomical areas connected through drug transfer processes such as absorption, metabolism, distribution, and elimination.
These models offer a more comprehensive representation of drug behavior in the body than one-compartment models. They accommodate the complexity of drug distribution,...
65
Physiological Pharmacokinetic Models: Assumption with Protein Binding01:13

Physiological Pharmacokinetic Models: Assumption with Protein Binding

24
Physiological models with protein binding in pharmacokinetics offer a sophisticated approach to understanding drug disposition. These models consider drug-protein interactions, enabling them to effectively predict drug concentrations in different organs and tissues. This precision aids in accurate drug dosing, providing a significant advantage over conventional models. A key process within these models is equilibration, which ensures that drug concentrations achieve a steady state within the...
24
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

47
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
47
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

22
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
22

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Pharmacogenomics and chronotherapy of drug-induced cardioprotection in acute myocardial infarction.

Nature communications·2025
Same author

Protein-Protein Binding Kinetics by Biolayer Interferometry.

Advances in experimental medicine and biology·2024
Same author

X-Ray Crystallography for Macromolecular Complexes.

Advances in experimental medicine and biology·2024
Same author

The crystal structure of iC3b-CR3 αI reveals a modular recognition of the main opsonin iC3b by the CR3 integrin receptor.

Nature communications·2022
Same author

Structures of T7 bacteriophage portal and tail suggest a viral DNA retention and ejection mechanism.

Nature communications·2019
Same author

Insights into the inhibited form of the redox-sensitive SufE-like sulfur acceptor CsdE.

PloS one·2017

相关实验视频

Updated: Jun 23, 2026

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction
09:20

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction

Published on: February 13, 2021

C模型:一个全面增强的药理动力学/药理动力学模拟环境,针对补充系统.

Lucía Alfonso-González1,2, M Cristina Vega2, Francisco J Fernández1

  • 1Abvance Biotech SL, Pharmacokinetics, Pharmacodynamics and Drug Metabolism (PPDM), Madrid, Spain.

British journal of pharmacology
|May 12, 2025
PubMed
概括

一个新的计算模型,C模型,有效地预测补充生物标志物和各种疾病的治疗反应. 这种工具有助于开发新疗法,并为补充相关疾病提供个性化的患者护理.

关键词:
在C3型淋巴细胞病变中.在C-模型中.非典型的血液溶解性尿素性病症综合征.互补系统是互补的系统.密集沉积病的疾病.增强了PK/PD的功能.

更多相关视频

A Modeling and Simulation Method for Preliminary Design of an Electro-Variable Displacement Pump
09:04

A Modeling and Simulation Method for Preliminary Design of an Electro-Variable Displacement Pump

Published on: June 1, 2022

Realistic Membrane Modeling Using Complex Lipid Mixtures in Simulation Studies
07:31

Realistic Membrane Modeling Using Complex Lipid Mixtures in Simulation Studies

Published on: September 1, 2023

相关实验视频

Last Updated: Jun 23, 2026

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction
09:20

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction

Published on: February 13, 2021

A Modeling and Simulation Method for Preliminary Design of an Electro-Variable Displacement Pump
09:04

A Modeling and Simulation Method for Preliminary Design of an Electro-Variable Displacement Pump

Published on: June 1, 2022

Realistic Membrane Modeling Using Complex Lipid Mixtures in Simulation Studies
07:31

Realistic Membrane Modeling Using Complex Lipid Mixtures in Simulation Studies

Published on: September 1, 2023

科学领域:

  • 免疫学 免疫学 免疫学
  • 计算生物学 计算生物学
  • 药理动力学是什么 药理动力学

背景情况:

  • 补体系统在许多疾病中至关重要,但由于疾病异质性和各种反应,治疗具有挑战性.
  • 了解补充激活途径和调节对于有效的疾病管理至关重要.

研究的目的:

  • 引入C模型,一个全面的计算环境来模拟补充系统.
  • 通过先进的建模来解决与补充相关疾病的管理方面的挑战.

主要方法:

  • C模型模拟了替代性,古典性和乳素补充激活通路,以及终端/lytic通路.
  • 该模型包括流体相和细胞相关调节 (红细胞,内皮细胞).
  • 它整合了实验患者数据和模拟药物效应.

主要成果:

  • 在健康和疾病状态下,C模型准确预测补充生物标志物.
  • 该模型预测了患者对各种治疗干预措施的反应.
  • 模拟数据是公开的,用于学术研究.

结论:

  • C模型是一种先进的药理动力学/药理动力学工具,支持新疗法开发.
  • 它通过启用场景模拟来促进个性化的患者管理.
  • 该模型增强了对补体系统在疾病中的作用的理解.